American Journal of Hematology · 2014 · 47 citations · 19 references
MedicinePublic HealthOncologyCancer EpidemiologyEpidemiologic MethodsEpidemiologyCancer DisparitiesCancer Health DisparitiesEthnic MinoritiesEthnicity In HealthCancer Epidemiology By EthnicityCancer Epidemiology By RaceEthnic Disparities Over TimeIncidence Across Age GroupsLymphoma EpidemiologyLymphoma PrevalenceRacial Cancer DisparitiesRacial Disparities Over Time
The impact of race/ethnicity and the additional factors of age, sex, and socioeconomic status (SES) on follicular lymphoma (FL) outcomes have not been comprehensively studied and are not well defined. We examined population-based FL data from >18,000 patients in SEER-13 (1992-2009) investigating race/ethnicity and the impact of relevant factors including sex, age, and SES. Further, we compared data over two consecutive periods: Era-1 (1992-2000, n = 8,355) and Era-2 (2001-2009, n = 10,475). We identified 18,830 FL patients (White: n = 15,116; Hispanic: n = 1,627; Asian/Pacific Islander (A/PI): n = 1,002; and Black: n = 846). Median ages (years) differed significantly by race/ethnicity: White: 62.1, Hispanic: 57.3, A/PI: 60.7, and Black: 56.8 (P < 0.01 each race versus White). Overall survival (OS) was superior in Era-2 versus Era-1 for all patients (5-year: 76.7% versus 67.4%, respectively, P < 0.001). Further, survival was significantly improved for all age groups <80 years, for males (P = 0.0019), and females (P < 0.001) across eras. Females had superior OS compared with males in Era-1 (P = 0.004), but not in Era-2. Additionally, all races, except A/PI, had improved 5-year OS rates from Era-1 to Era-2. Finally, OS improved across eras for lower and higher SES populations; however those with higher SES were superior to lower SES patients in both eras. In conclusion, and in the largest comprehensive evaluation of US-based FL patients to date, we show that despite improvements in OS for FL over time, critical disparities across races/ethnicities, sex, and age groups remain in the modern era and warrant further studies.
19
Ahmedin Jemal, Freddie Bray, Jacques Ferlay et al. · CA A Cancer Journal for Clinicians · 2011 · 55K citations · Full text
Follicular Lymphoma International Prognostic Index
Blood · 2004 · 1.5K citations · Full text
Medicine, Hematology, Oncology +16
Massimo Federico, Monica Bellei, Luigi Marcheselli et al. · Journal of Clinical Oncology · 2009 · 751 citations · Full text
Association of Insurance with Cancer Care Utilization and Outcomes
Elizabeth Ward, Michael T. Halpern, Nicole M. Schrag et al. · CA A Cancer Journal for Clinicians · 2008 · 738 citations · Full text